Potassium iodide remains the most effective therapy for cutaneous sporotrichosis

Journal of Dermatological Treatment

Volumn 14, Issue 4, 2003, Pages 200-202

  Sandhu, K ^a   Gupta, Somesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cutaneous sporotrichosis; Itraconazole; Potassium iodide

Indexed keywords

ITRACONAZOLE; POTASSIUM IODIDE;

CLINICAL FEATURE; DERMATOMYCOSIS; DRUG EFFECT; DRUG TOLERABILITY; EXTERNAL EAR; GASTROINTESTINAL SYMPTOM; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; NONHUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; POTASSIUM IODIDE; SEVERITY OF ILLNESS INDEX; SPOROTRICHOSIS; TREATMENT OUTCOME;

EID: 0345304785     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630310020452     Document Type: Review

References (13)

1. Rippon JW. Sporotrichosis. In: Rippon JW (ed) Medical mycology: the pathogenic fungi and the pathogenetic actinomycetes, 3rd ed. WB Saunders: Philadelphia. PA. 1988. pp. 325-52.
2. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis (2000) 30: 684-7.
3. CA Kaufmann. Old and new therapies for sporotrichosis. Clin Infect Dis (1995) 21: 981-5.
4. Sharkey-Mathis PK, Kauffman CA, Graybill JR et al. Treatment of sporotrichosis. Am J Med (1993) 95: 279-85.
5. Restrepo A, Robledo J, Gomez I et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol (1986) 122: 413-17.
6. Conti Diaz IA, Civilia E, Gezuele E et al. Treatment of human sporotrichosis with itraconazole. Mycoses (1992) 35: 153-6.
7. Winn RE, Anderson J, Piper J et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis (1993) 17: 210-17.
8. Sterling BJ, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century: uses. pharmacology, adverse effects and contraindications. J Am Acad Dermatol (2000) 43: 691-7.
9. Tio T, Vries G. Subcutaneous zygomycosis. S Afr Med J (1977) 52: 77-8.
10. Rex JH, Bennett JE. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol (1990) 28: 185-9.
11. Honma K, Saga K, Onudera H, Takahashi M. Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol (1990) 70: 247-9.
12. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leucocytes derived oxygen intermediates. Br J Dermatol (1982) 107: 209-14.
13. Hiruma M, Kagawa S. Ultrastructure of Sporothrix schenckii with iodine-potassium iodide solution. Mycopathologica (1987) 97: 121-7.